Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.

Kuroshima S, Yamashita J.

Bone. 2013 Sep;56(1):101-9. doi: 10.1016/j.bone.2013.05.013. Epub 2013 May 28.

PMID:
23727433
2.

Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.

de Molon RS, Cheong S, Bezouglaia O, Dry SM, Pirih F, Cirelli JA, Aghaloo TL, Tetradis S.

Bone. 2014 Nov;68:11-9. doi: 10.1016/j.bone.2014.07.027. Epub 2014 Aug 2.

3.

OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.

de Molon RS, Shimamoto H, Bezouglaia O, Pirih FQ, Dry SM, Kostenuik P, Boyce RW, Dwyer D, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2015 Sep;30(9):1627-40. doi: 10.1002/jbmr.2490. Epub 2015 May 27.

4.

Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.

Park S, Kanayama K, Kaur K, Tseng HC, Banankhah S, Quje DT, Sayre JW, Jewett A, Nishimura I.

J Biol Chem. 2015 Jul 10;290(28):17349-66. doi: 10.1074/jbc.M115.652305. Epub 2015 May 26.

5.

Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.

Kang B, Cheong S, Chaichanasakul T, Bezouglaia O, Atti E, Dry SM, Pirih FQ, Aghaloo TL, Tetradis S.

J Bone Miner Res. 2013 Jul;28(7):1631-40. doi: 10.1002/jbmr.1894.

6.

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel.

Miyazaki H, Nishimatsu H, Kume H, Suzuki M, Fujimura T, Fukuhara H, Enomoto Y, Ishikawa A, Igawa Y, Hirano Y, Homma Y.

BJU Int. 2012 Dec;110(11 Pt B):E520-5. doi: 10.1111/j.1464-410X.2012.11205.x. Epub 2012 May 11.

7.

Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.

Ersan N, van Ruijven LJ, Bronckers AL, Olgaç V, Ilgüy D, Everts V.

Dentomaxillofac Radiol. 2014;43(1):20130144. doi: 10.1259/dmfr.20130144. Epub 2013 Oct 29.

8.

Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.

Kuroshima S, Entezami P, McCauley LK, Yamashita J.

Osteoporos Int. 2014 Mar;25(3):1141-50. doi: 10.1007/s00198-013-2570-8. Epub 2013 Dec 4.

9.

Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma.

Smidt-Hansen T, Folkmar TB, Fode K, Agerbaek M, Donskov F.

J Oral Maxillofac Surg. 2013 Sep;71(9):1532-40. doi: 10.1016/j.joms.2013.03.019. Epub 2013 May 1.

PMID:
23642545
10.

Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?

Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z, Agacayak F, Ilgun S, Tecimer C, Demir G, Eralp Y, Okkan S, Ozmen V.

Medicine (Baltimore). 2015 May;94(18):e671. doi: 10.1097/MD.0000000000000671.

11.

Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.

Cetiner S, Sucak GT, Kahraman SA, Aki SZ, Kocakahyaoglu B, Gultekin SE, Cetiner M, Haznedar R.

J Bone Miner Metab. 2009;27(4):435-43. doi: 10.1007/s00774-009-0047-9. Epub 2009 Feb 26.

PMID:
19240969
12.

Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis.

Aguirre JI, Akhter MP, Kimmel DB, Pingel JE, Williams A, Jorgensen M, Kesavalu L, Wronski TJ.

J Bone Miner Res. 2012 Oct;27(10):2130-43. doi: 10.1002/jbmr.1669.

13.

Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients.

Lescaille G, Coudert AE, Baaroun V, Ostertag A, Charpentier E, Javelot MJ, Tolédo R, Goudot P, Azérad J, Berdal A, Spano JP, Ruhin B, Descroix V.

Bone. 2014 Jan;58:103-7. doi: 10.1016/j.bone.2013.10.002. Epub 2013 Oct 9.

PMID:
24120382
14.

Impaired bone resorption and woven bone formation are associated with development of osteonecrosis of the jaw-like lesions by bisphosphonate and anti-receptor activator of NF-κB ligand antibody in mice.

Williams DW, Lee C, Kim T, Yagita H, Wu H, Park S, Yang P, Liu H, Shi S, Shin KH, Kang MK, Park NH, Kim RH.

Am J Pathol. 2014 Nov;184(11):3084-93. doi: 10.1016/j.ajpath.2014.07.010. Epub 2014 Aug 28.

15.

Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.

Kobayashi Y, Hiraga T, Ueda A, Wang L, Matsumoto-Nakano M, Hata K, Yatani H, Yoneda T.

J Bone Miner Metab. 2010 Mar;28(2):165-75. doi: 10.1007/s00774-009-0128-9. Epub 2009 Oct 31.

PMID:
19882100
16.

Antiresorptives and osteonecrosis of the jaw.

Yamashita J, McCauley LK.

J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):233-47. doi: 10.1016/S1532-3382(12)70046-5. Review.

PMID:
23040351
17.

Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.

Voss P, Ludwig U, Poxleitner P, Bergmaier V, El-Shafi N, von Elverfeldt D, Stadelmann V, Hövener JB, Flügge T.

Dentomaxillofac Radiol. 2016;45(4):20150250. doi: 10.1259/dmfr.20150250. Epub 2016 Feb 5.

PMID:
26846710
18.

Absence of exposed bone following dental extraction in beagle dogs treated with 9 months of high-dose zoledronic acid combined with dexamethasone.

Allen MR, Chu TM, Ruggiero SL.

J Oral Maxillofac Surg. 2013 Jun;71(6):1017-26. doi: 10.1016/j.joms.2012.11.016. Epub 2013 Feb 1.

19.

Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.

Hokugo A, Christensen R, Chung EM, Sung EC, Felsenfeld AL, Sayre JW, Garrett N, Adams JS, Nishimura I.

J Bone Miner Res. 2010 Jun;25(6):1337-49. doi: 10.1002/jbmr.23.

20.

Effect of local vs. systemic bisphosphonate delivery on dental implant fixation in a model of osteonecrosis of the jaw.

Abtahi J, Agholme F, Sandberg O, Aspenberg P.

J Dent Res. 2013 Mar;92(3):279-83. doi: 10.1177/0022034512472335. Epub 2012 Dec 21.

PMID:
23264610
Items per page

Supplemental Content

Write to the Help Desk